Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment - Concepedia

Concepedia

Publication | Open Access

Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment

DOI Full Paper Access

121

Citations

3

References

2020

Year

Konrad Rejdak, Paweł Grieb

Multiple Sclerosis and Related Disorders

Neurodegenerative DiseasesPharmacologyNeurologyMultiple SclerosisNeurological DiseasesMedicineCovid-19

References

	Year	Citations

Page 1